Liver Medicine Trials

  • 05/07/2019


    Beta-blocker Stratification using quantitative MRI techniques to assess portal pressure and Response to Treatment in patients with portal hypertension.

    View Trial
  • 28/02/2020

    Protocol for a prospective cohort study to develop and validate AScites Quality of Life questionnaire (ASQoL)

    View Trial
  • 31/12/2012

    Review of renal dysfunction in recipients of orthotopic liver allografts in the UK

    View Trial
  • NIHR BioResource – Research Tissue Bank

    View Trial
  • 31/10/2022


    The European NAFLD Registry – LITMUS (Liver Investigation: Testing Marker Utility in Steatohepatitis)

    View Trial
  • 31/12/2021


    A Multicenter Randomized Double-Blind Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

    View Trial
  • 30/06/2024

    The REGENERATE Study

    A Phase 3 Double-Blind Randomized Long-Term Placebo-Controlled Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis

    View Trial
  • 31/07/2015

    Chart Review To Characterise Resource Utilisation Associated With Managing Non-infant Lysosomal Acid Lipase Deficiency

    View Trial
  • 01/05/2019

    A multi-centre double-blind parallel-group randomised placebo controlled phase II a study to investigate safety tolerability pharmacodynamics and pharmacokinetics of different doses of orally administered BI 1467335 during a 12-week treatment period compared to placebo in patients with clinical evidence of NASH.

    View Trial
  • 30/08/2020


    AURORA: A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis

    View Trial